nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—TYMS—cleft lip	0.938	1	CbGaD
Capecitabine—TYMS—One Carbon Metabolism—MTHFS—cleft lip	0.00792	0.128	CbGpPWpGaD
Capecitabine—DPYD—Pyrimidine metabolism—TYMS—cleft lip	0.00387	0.0627	CbGpPWpGaD
Capecitabine—CDA—Pyrimidine metabolism—TYMS—cleft lip	0.00345	0.0558	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TYMS—cleft lip	0.003	0.0486	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—TCN2—cleft lip	0.00293	0.0475	CbGpPWpGaD
Capecitabine—TYMP—Pyrimidine metabolism—TYMS—cleft lip	0.00275	0.0446	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TYMS—cleft lip	0.00267	0.0433	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00262	0.0424	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00233	0.0378	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TYMS—cleft lip	0.00213	0.0346	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—MTR—cleft lip	0.00203	0.0329	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00187	0.0302	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—MTR—cleft lip	0.00183	0.0296	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—FGFR3—cleft lip	0.00179	0.0291	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—EPHA3—cleft lip	0.00175	0.0284	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TYMS—cleft lip	0.00157	0.0255	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—TYMS—cleft lip	0.00151	0.0244	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00137	0.0223	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—TYMS—cleft lip	0.00134	0.0218	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—MTHFR—cleft lip	0.00109	0.0176	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—TYMS—cleft lip	0.00107	0.0174	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cleft lip	0.000978	0.0158	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—MTHFR—cleft lip	0.000954	0.0155	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MYC—cleft lip	0.000906	0.0147	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—TYMS—cleft lip	0.000834	0.0135	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFA—cleft lip	0.000815	0.0132	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.000631	0.0102	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC19A1—cleft lip	0.000389	0.0063	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC19A1—cleft lip	0.000346	0.00561	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—cleft lip	0.000337	0.00546	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TCN2—cleft lip	0.000322	0.00522	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TCN2—cleft lip	0.000287	0.00465	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC19A1—cleft lip	0.000277	0.00449	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—cleft lip	0.000234	0.00379	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TCN2—cleft lip	0.000229	0.00372	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000227	0.00368	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MTR—cleft lip	0.000223	0.00362	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—cleft lip	0.000203	0.00329	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTR—cleft lip	0.000199	0.00322	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—cleft lip	0.00017	0.00275	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000166	0.00268	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTR—cleft lip	0.000159	0.00258	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—cleft lip	0.000143	0.00232	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC19A1—cleft lip	0.000142	0.0023	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—MTR—cleft lip	0.000137	0.00222	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TYMS—cleft lip	0.000137	0.00222	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TYMS—cleft lip	0.000122	0.00198	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MTHFR—cleft lip	0.000119	0.00194	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—TCN2—cleft lip	0.000117	0.0019	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000108	0.00175	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTHFR—cleft lip	0.000106	0.00173	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TYMS—cleft lip	9.75e-05	0.00158	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—cleft lip	8.51e-05	0.00138	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NOS3—cleft lip	8.33e-05	0.00135	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTR—cleft lip	8.13e-05	0.00132	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NOS3—cleft lip	7.43e-05	0.0012	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NOS3—cleft lip	5.94e-05	0.000962	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—cleft lip	5.24e-05	0.00085	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—cleft lip	4.69e-05	0.00076	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—cleft lip	4.36e-05	0.000706	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC19A1—cleft lip	4.08e-05	0.000662	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TCN2—cleft lip	3.38e-05	0.000548	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—cleft lip	3.04e-05	0.000492	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTR—cleft lip	2.34e-05	0.00038	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMS—cleft lip	1.44e-05	0.000233	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—cleft lip	1.26e-05	0.000203	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—cleft lip	8.76e-06	0.000142	CbGpPWpGaD
